Axcella Health Inc. (AXLA): Price and Financial Metrics
GET POWR RATINGS... FREE!
AXLA Stock Price Chart Interactive Chart >
AXLA Price/Volume Stats
| Current price | $0.68 | 52-week high | $2.89 |
| Prev. close | $0.63 | 52-week low | $0.16 |
| Day low | $0.61 | Volume | 220,919 |
| Day high | $0.68 | Avg. volume | 1,780,635 |
| 50-day MA | $0.60 | Dividend yield | N/A |
| 200-day MA | $1.56 | Market Cap | 50.02M |
Axcella Health Inc. (AXLA) Company Bio
Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.
Latest AXLA News From Around the Web
Below are the latest news stories about AXCELLA HEALTH INC that investors may wish to consider to help them evaluate AXLA as an investment opportunity.
Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & MoreUpdates from bluebird (BLUE) and Catalyst Pharmaceuticals (CPRX) are the key highlights from the biotech sector during the past week. |
With lean staff, low cash, Axcella races ahead with Long Covid drugAxcella Therapeutics Inc. has one of the most advanced potential drugs for Long Covid in the industry. It also has only enough cash runway to get it through the second quarter of this year, making for a mad-dash effort to get that drug through clinical trials. |
Why Is Axcella Health (AXLA) Stock Up 66% Today?Axcella Health (AXLA) stock is rocketing higher on Tuesday after revealing a regulatory path to registration for AXA1125. |
Why Is LogicMark (LGMK) Stock Down 36% Today?LogicMark (LGMK) stock is falling on Tuesday after the medical device company priced a $5.2 million public offering of its shares. |
Why Is Novo Integrated Sciences (NVOS) Stock Up 27% Today?Novo Integrated Sciences (NVOS) stock is taking off on Tuesday despite a lack of news concerning the healthcare company. |
AXLA Price Returns
| 1-mo | 107.63% |
| 3-mo | -33.98% |
| 6-mo | -73.02% |
| 1-year | -60.23% |
| 3-year | -85.95% |
| 5-year | N/A |
| YTD | 107.63% |
| 2022 | -84.33% |
| 2021 | -59.73% |
| 2020 | 29.43% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...